CTRI/2021/12/038506
Completed
未知
â?? EVALUATION OF BIOLOGICAL, MECHANICAL AND PATIENT REPORTED PARAMETERS ASSOCIATED WITH ANGULATED SCREW CHANNEL ABUTMENTS AND MULTI UNIT ABUTMENTS FOR FABRICATION OF SCREW RETAINED IMPLANT CROWNS IN ANTERIOR ESTHETIC ZONE â?? AN IN VIVO STUDY.â?¿
Dynamic Abutment Solutions0 sites20 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: K084- Partial loss of teeth
- Sponsor
- Dynamic Abutment Solutions
- Enrollment
- 20
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\)Patient willing for the procedure (the study is explained, including the procedure and follow up for evaluation)
- •2\)Patient that has good oral hygiene and periodontal health (patients that can follow up for evaluation)
- •3\)Sufficient mesio\-distal, bucco\-lingual, and interocclusal space for placement of an anatomic restoration
- •4\)Implant site free from infection
Exclusion Criteria
- •1\.Medical and general contraindications for the surgical procedures
- •2\.Presence of active and uncontrolled periodontal disease
- •3\.History of local radiotherapy to the head and neck region.
- •4\.Systemic diseases (Uncontrolled diabetes, recent MI, valvular prosthesis surgery, bleeding disorders, acute renal failure, immunosuppression).
- •5\.Patients in intravenous bisphosphonate.
- •6\.Psychiatric illness
- •7\.Chronic heavy smokers
- •8\.History of head and neck irradiation in the last 6 months.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Evaluation of the quality of scars resulting from the treatment of burn sequelae with or without the use of dermal matricesRBR-3v26fmHospital das clínicas da faculdade de medicina de Ribeirão Preto da Universidade de São Paulo
Active, not recruiting
Phase 1
Evaluation of the combined use of Onabotulinumtoxin A and hyaluronic acid fillers in patients with facial paralysishemifacial paralysis (3 to 6 of the House-Brackmann scale)MedDRA version: 20.1Level: LLTClassification code 10016060Term: Facial palsySystem Organ Class: 100000004852Therapeutic area: Diseases [C] - Nervous System Diseases [C10]EUCTR2018-004696-12-ITAZIENDA OSPEDALIERA UNIVERSITARIA INTEGRATA VERONA70
Active, not recruiting
Not Applicable
Ocriplasmin for Vitreomacular Traction/Symptomatic Vitreomacular AdhesioVitreomacular Traction/ Symptomatic Vitreomacular AdhesionMedDRA version: 18.0Level: LLTClassification code 10070236Term: Vitreomacular adhesionSystem Organ Class: 100000004853MedDRA version: 18.0Level: LLTClassification code 10051065Term: Vitreomacular traction syndromeSystem Organ Class: 100000004853Therapeutic area: Diseases [C] - Eye Diseases [C11]EUCTR2013-005464-25-FRAlcon Research, Ltd.474
Active, not recruiting
Not Applicable
Ocriplasmin for Vitreomacular Traction/Symptomatic Vitreomacular AdhesioVitreomacular Traction/ Symptomatic Vitreomacular AdhesionMedDRA version: 16.1Level: LLTClassification code 10070236Term: Vitreomacular adhesionSystem Organ Class: 100000004853MedDRA version: 16.1Level: LLTClassification code 10051065Term: Vitreomacular traction syndromeSystem Organ Class: 100000004853Therapeutic area: Diseases [C] - Eye Diseases [C11]EUCTR2013-005464-25-ESAlcon Research, Ltd.474
Completed
Phase 4
Assessment of Anatomical and Functional Outcomes in Patients Treated with Ocriplasmin for Vitreomacular Traction/Symptomatic Vitreomacular Adhesion (VMT/sVMA)Vitreomacular traction10047060NL-OMON40974Alcon Laboratories50